Many neurological diseases share similar symptoms, making correct diagnosis difficult and impacting the treatment of patients. While Alzheimer's Disease has made advancements in its diagnostic criteria becoming more based on biology, Parkinson's Disease and other neurological conditions lag behind and remain diagnosed mainly based on clinical presentation.

Dr Ruiqing Ni is leading the NeuroPAT project, a collaboration between the University Hospital Zurich, ETH Zurich, the University of Zurich, the University Hospital Bern, and the University of Aachen. They aim to develop a biological definition of neurological diseases, detecting molecular changes in the brain, which will help detect and treat the disease.